# Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

> **NCT02948855** · — · WITHDRAWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital**

## Conditions studied

- Thymoma
- Autoimmune Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02948855
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-10
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Improper design of the trial and no participants enrolled.
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02948855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02948855, "Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02948855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*